MichaelJDochertyMD

Advanced Endoscopic Interventional

Assistant Professor, Medicine, UCSD School of Medicine

Dr. Docherty is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
200 W Arbor Dr
San Diego, CA 92103
Phone+1 800-926-8273

Fax+1 888-539-8781

University of California (San Diego) Medical CenterFellowship, Gastroenterology, 2002 - 2005
University of California (San Diego) Medical CenterResidency, Internal Medicine, 1999 - 2002
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 1999

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013

PubMed

3 citations
The ClC-2 Chloride Channel Activator, Lubiprostone, Improves Intestinal Barrier Function in Biopsies from Crohn's Disease but Not Ulcerative Colitis Patients.
Young Su Park, Sang Bum Kang, Ronald R Marchelletta, Harrison M Penrose, Roos Ruiter-Visser
Pharmaceutics. 2023-03-02
7 citations
AMPK mediates inhibition of electrolyte transport and NKCC1 activity by reactive oxygen species
Stephanie J. King, Michael Bunz, Alfred E. Chappell, Michael Scharl, Michael J. Docherty
American Journal of Physiology. Gastrointestinal and Liver Physiology. 2019-08-01
5 citations
A comparison of linaclotide and lubiprostone dosing regimens on ion transport responses in human colonic mucosa
Sang Bum Kang, Ronald R. Marchelletta, Harrison M. Penrose, Michael J. Docherty, Declan F. McCole
Pharmacology Research & Perspectives. 2015-03-01

Lectures

2nd Annual Symposium on Controversies in Inflammatory Bowel Disease
University of California San Diego, San Diego, California - 1/28/2012